Renal biopsy - indication and its implications in management of children admitted at a tertiary care hospital, Mangalore
DOI:
https://doi.org/10.18203/2349-3291.ijcp20231049Keywords:
Percutaneous renal biopsy, Clinical diagnosis, Histopathology findings, ComplicationsAbstract
Background: Percutaneous renal biopsy is an established diagnostic tool for identification of renal pathology required for diagnosis, treatment, and prognostication. The present study was conducted to know the common indications and histopathological findings of renal biopsy, impact of biopsy report on treatment, and complications of procedure.
Methods: This was a retrospective observational study conducted in the paediatric ward of a tertiary care level hospital. Indications of renal biopsy as suggested by medical records were noted down. Any treatment changes happened after final histopathological report were recorded. Statistical analysis was made using statistical package for the social sciences (SPSS) version 20.0 (IBM, NY).
Results: The mean age of patients at which biopsy was done was 9.83±5.31 years. Most common indications of renal biopsy were nephritic onset nephrotic syndrome (34.8%), steroid-resistant nephrotic syndrome (21.7%), steroid-dependent nephrotic syndrome requiring calcineurin inhibitors (CNI) (17.4%), lupus nephritis (8.7%), nephrotic syndrome with later age of onset (8.7%), acute kidney injury (AKI) stage 3 (4.3%) and for evidence of calcineurin inhibitor toxicity (4.3%). Focal segmental glomerulosclerosis (26.1%), minimal change disease (21.7%) and membranoproliferative glomerulonephrosis (17.4%) were the most common histopathological findings.
Conclusions: This study reiterates the fact that renal biopsy is one of the decisive and diagnostic procedures and has good prognostic value in further management of medical renal disease.
References
Warady BA, Chadha V. Chronic kidney disease in children: the global perspective. Pediatric Nephrol. 2007;22:1999-2009.
Dhaun N, Bellamy CO, Cattran DC, Kluth DC. Utility of renal biopsy in the clinical management of renal disease. Kidney Int. 2014;85(5):1039-48.
Kielstein JT, Böger RH, Bode-Böger SM, Frölich JC, Haller H, Ritz E, Fliser D. Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. J Am Soc Nephrol. 2002;13(1):170-6.
Rizvi SA, Manzoor K. Causes of chronic renal failure in Pakistan: a single large center experience. Saudi J Kidney Dis Transplant. 2002;13(3):376-9.
Gaut JP, Liapis H. Acute kidney injury pathology and pathophysiology: a retrospective review. Clinical Kidney Journal. 2021 Feb;14(2):526-36.
Nammalwar BR, Vijayakumar M, Prahlad N. Experience of renal biopsy in children with nephrotic syndrome. Pediatric Nephrol. 2006;21:286-8.
Santangelo L, Netti GS, Giordano P, Carbone V, Martino M, Torres DD, et al. Indications and results of renal biopsy in children: a 36-year experience. World J Pediatr. 2018;14(2):127-133.
Kumar J, Gulati S, Sharma AP, Sharma RK, Gupta RK. Histopathological spectrum of childhood nephrotic syndrome in Indian children. Pediatric Nephrol. 2003;18:657-60.
Prada Rico M, Rodríguez Cuellar CI, Fernandez Hernandez M, González Chaparro LS, Prado Agredo OL, Gastelbondo Amaya R. Characterization and etiopathogenic approach of pediatric renal biopsy patients in a colombian medical center from 2007-2017. Int J Nephrol. 2018;28.
Mallouk A, Pham PT, Pham PC. Concurrent FSGS and Hodgkin's lymphoma: case report and literature review on the link between nephrotic glomerulopathies and hematological malignancies. Clin Exp Nephrol. 2006;10:284-9.
Stratta P, Canavese C, Marengo M, Mesiano P, Besso L, Quaglia M, et al. Risk management of renal biopsy: 1387 cases over 30 years in a single centre. Eur J Clin Invest. 2007;37(12):954-63.
